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Abstract
Sclerosing rhabdomyosarcoma (SRMS) is an infrequent variant of rhabdomyosarcoma characterized by extensive
intercellular hyaline fibrosis. We report the case of a 37 year-old male with a 9 × 6 cm SRMS on the right elbow.
Histologically, the tumor showed an abundant extracellular hyaline matrix with extratumoral vascular emboli and
microscopic foci of fusocellular embryonal rhabdomyosarcoma (FRMS) separated by a fibrotic band from the scler-
osing areas. One year later the patient presented with a right intratesticular tumor of 1.2 × 0.8 cm, which was
reported as pure FRMS. Immunohistochemically, SRMS was positive only for MyoD1 and Vimentin and negative for
Myogenin and Desmin. Both the elbow emboli with the extratumoral foci of FRMS and the intratesticular tumor
were positive for Myogenin, MyoD1, Vimentin and Desmin. Using fluorescent in situ hybridization (FISH), the SRMS
and the FRMS tumor cells of the elbow and the FRMS tumor cells of the testis were found to be negative for
FOXO1A translocation in chromosome 13. PCR chimeric transcriptional products PAX3-FKHR and PAX7-FKHR were
not found. Six months following testicular resection, the patient died of multiple metastases in the mediastinum,
lung and right thigh.
Background
Rhabdomyosarcoma (RMS) is the most common sar-
coma developed during childhood. It is a devastating
tumor displaying characteristics of muscle differentia-
tion. Rhabdomyosarcoma currently is classified into
three main groups: (i) embryonal (ERMS), (ii) alveolar
(ARMS) and (iii) pleomorphic (PRMS), each of which
can show several significant clinical, morphological,
molecular and prognostic differences. ERMS tumor
cells, including its variants, botryoid, anaplastic and
spindle or fusocellular cells (FRMS), often occur in
infants and adults [1]. In non-pediatric cases embryonal
rhabdomyosarcoma usually appears in the head, neck
and extremities, and does not contain PAX3/FOXO1A
or PAX7/FOXO1A fusion proteins, expressing clearly all
muscle immunohistochemical markers. The sclerosing
variant of rhabdomyosarcomas (SRMS) was first
described by Mentzel and Katenkamp [2]; 16 cases in
adults have been reported [2-8], all of which share the
particular characteristic of diffuse hyaline fibrosis sur-
rounding the sarcomatoid cells. Although sclerosing
rhabdomyosarcoma has not yet been classified among
the different types of RMS, some authors consider that
it could be the same neoplasm [9] or a subtype of fuso-
cellular rhabdomyosarcoma on the basis of histological,
immunohistochemical and chromosomal changes [3].
We present a case of sclerosing rhabdomyosarcoma of
elbow showing extratumoral intravascular emboli and
stromal external foci of fusocellular rhabdomyosarcoma,
histologically and immunohistochemically identical to
the metastasis that appeared one year later in the right
testis. In our opinion this case supports a close histo-
genic relationship between sclerosing and fusocellular
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rhabdomyosarcoma, given that we could not exclude
sclerosing rhabdomyosarcoma as representing a histolo-
gical type of fusocellular rhabdomyosarcoma.
Case presentation
A 37 year-old male without significant previous medical
history, presented in June 2007 with a solitary soft tissue
mass in the posterior side of the right elbow, with rapid
growth that did not infiltrate the bone or the skin. The
patient underwent a tumorectomy with wide margins.
Following histological study, he received three cycles of
chemotherapy (CTX+VCR+Doxorrubicin). One year
after tumorectomy, a “de novo” intratesticular tumor
appeared in the right testis, not previously detected.
Orchiectomy was subsequently performed. A second
line of chemotherapy (Ifosfamide) followed, but without
positive response. Eight months following the orchiect-
omy, the patient died with multiple metastases in the
left thigh, lung and mediastinum. No autopsy was per-
formed (Figure 1)
The tumors were processed in molecular fixative solu-
tion for Tissue-Tek Xpress Rapid Tissue Processor®
(Sakura), embedded in paraffin, cut in 4 μm thick sec-
tions and stained with hematoxylin and eosin for rou-
tine histological examination. Immunohistochemical
analysis was done on the paraffin-embedded sections
using standard protocol. Primary antibodies were:
MyoD1 (Dako, diluted 1:50), Vimentin (Dako, diluted
1:100), Myogenin (Dako, diluted 1:50), SMA (specific
muscle actin) (Dako, diluted 1:100), Desmin (Dako,
diluted 1:100), EMA (Dako, Diluted 1:50), CD 99 (Signet
Laboratories, Dehman, MA, USA, diluted 1:50), p57
(Dako, diluted 1:200), CD 56 (Dako, diluted 1:200), S100
protein (Dako, diluted 1:100), CEAp (Dako, diluted
1:400), CD31 (Dako, diluted 1:1000), CD34 (Dako,
diluted 1:1000), MIB 1 (Dako, diluted 1:400), and pan-
cytokeratin (AE1/AE3, Dako Glostrup, Denmark, diluted
1:50). Fluorescence in situ hybridization (FISH) and RT-
PCR were carried out on the paraffin-embedded sections
from the elbow and testicle tumors. For FISH we used
the Poseidon Repeat Free FKHR (13q14) protocol (Krea-
tech Diagnostics, Amsterdam, the Netherlands). The
probe used was FKHR (FOXO1A, 13q14) Break apart
(POSEIDON). There are two critical regions: (i) critical
region 1 (red), in which the distal FKHR gene region
probe was directly labeled with Platinum Bright 550;
and (ii) critical region 2 (green), in which the proximal
FKHR gene region probe was directly labeled with Plati-
num Bright 495. Analysis was performed with a fluores-
cent microscope, and the software used for image
interpretation was CW4000. RT-PCR was performed as
previously reported [4], using adequate primers to detect
the chimeric transcriptional products PAX3-FKHR and
PAX7-FKHR.
Grossly the surgical specimen from the elbow showed
a 9 × 6 cms nodular solid tumor, white in color with a
glistening surface, infiltrating the surrounding skeletal
muscle.
Histologically, the tumor had abundant esosinophilic
hyalinizing sclerotic matrix, containing predominant
small round cells growing in small nests of fascicular,
pseudovascular cord-like or single file. In some areas a
predominant perivascular tumor growth was observed.
No microalveolar pattern was seen. Wreath-like tumor
cells and strap rhabdomyoblasts were not identified.
Mitotic activity was up to 4 mitotic figures/10 HPF.
Coagulative necrosis occupied 10% of the tumor mass.
On hematoxylin and eosin findings an initial diagnosis
Figure 1 CT Scan showing tumor progression. Eight months after testicular resection, the left lung was completely occupied by a metastatic
tumor mass involving mediastinum. The left thigh was also affected by the metastases.
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of sclerosing sarcoma, most probably epitheloid scleros-
ing fibrosarcoma was reached (Figure 2).
Immunohistochemically the tumor cells strongly
expressed Vimentin, MyoD1, SMA and CD99, being
negative for the remaining antibodies tested, including
Myogenin and Desmin. The proliferation index mea-
sured with MIB 1 was about more than 25%-30% of
tumor cells.
FISH hybridization did not show FOXO1A: 13q14
translocation and the chimeric transcriptional products
PAX3-FKHR and PAX7-FKHR were also not found (Fig-
ure 3).
On gross examination the orchiectomy specimen
showed a peripheral subalbuginea intratesticular well-
defined nodular tumor of 1.2 × 0.8 cms, grey to white
with solid consistency, with central necrosis and delim-
ited by a fibrous capsule from the normal testicular par-
enchyma. Histologically the tumor showed features of
fusocellular rhabdomyosarcoma, composed of fascicles
of spindle-shaped cells with small oval or elongated
nuclei, vesicular chromatin and pale cytoplasm. Occa-
sionally scattered in the tumor were a small number of
spindled or polygonal cells with excentrically placed
nuclei and abundant eosinophilic cytoplasm, resembling
more mature rhabdomyoblasts, were also seen. Mitotic
activity was more than 10 mitotic figures/10 HPF. The
tumor infiltrated the surrounding testicular parenchyma
and was centrally necrosed (30%). Immunohistochemi-
cally the cells stained positively for Vimentin, MyoD1,
CD99, Myogenin, Desmin, SMA and WT-1. The
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Figure 2 Histological features from the surgical specimen from the elbow. a: Tumor with abundant esosinophilic hyalinizing sclerotic
matrix (10×). b: Immunohistochemical staining positive for MyoD1 (20×). c: Sclerosing area (#) with fusocellular foci (*) and vascular emboli () of
FRMS (10×). d: Vascular emboli of FRMS (20×). e: Sclerosing rhabdomyosarcoma separated from FRMS foci by a fibrotic band (10×). f: FRMS foci
with spindle-shaped cells and rhabdomyoblastic differentiation (40x).
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proliferation index measured with MIB was about 20%.
Again, FISH failed to show the FOXO1A: 13q14 translo-
cation and the chimeric transcriptional products PAX3-
FKHR and PAX7-FKHR were not found.
After the histological diagnosis of the surgical specimen
from the testicular lesion, a complete sampling of the
sclerosing rhabdomyosarcoma from the elbow treated
one year before was performed. An extensive histological
study of the new samples demonstrated new histological
findings, such as the presence of two large endovascular
(venous) emboli and 3 minute foci of tumor (measuring
all together less than 3 mm) located in the non-tumoral
soft tissue, next to the sclerosing rhabdomyosarcoma and
apparently isolated from them by a fibrotic acellular
band. Histologically, tumor cells from the emboli and
extratumoral foci showed predominant fusocellular mor-
phology. A few isolated round primitive cells without
sclerosis and strap rhabdomyoblastic cells were also pre-
sent. Immunohistochemically these cells expressed
Vimentin, MyoD1, Myogenin, CD 99, SMA and Desmin,
being histologically and immunohistologically identical to
the testicular tumor studied one year later (Table 1 and
Figure 3).
Discussion
We have presented a unique case of a 37 year-old male
diagnosed with sclerosing rhabdomyosarcoma in the
elbow containing vascular emboli and peritumoral
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Figure 3 Histological and molecular features of testicular FRMS. a: Peripheral FRMS subalbuginea intratesticular well-defined nodular tumor
(10×), infiltrating the surrounding testicular parenchyma (insert) (20×). b: Fascicles of spindle-shaped cells with small oval or elongated nuclei,
vesicular chromatin and pale cytoplasm accompanied by rhabdomyoblastic differentiation (40×). c and d: Immunohistochemical staining was
positive for MyoD1 and Myogenin. E: FISH hybridization negative FOXO1A: 13q14 translocation, in the elbow sclerosing rhabdomyosarcoma. f:
FISH hybridization did not show FOXO1A: 13q14 translocation, in the FRMS.
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microscopic foci of fusocellular rhabdomyosarcoma. He
developed a pure intratesticular fusocellular rhabdomyo-
sarcoma one year after the initial diagnosis.
Sclerosing rhabdomyosarcoma is an infrequent
tumor. In adults only 16 cases have been reported.
These bearing a slight male predominance: the overall
median age at diagnosis was 46.6 years (range 18-79
years), and most frequently appeared as tumors of the
extremities as well as the head and neck region [5-7];
their prognoses appeared worse than previously
reported [7]. Among the cases with available follow-up
reported, four presented metastasis or died between 7
to 48 months after diagnosis [5,7,10]; six had recur-
rences or residual tumor [2,5,6,8,9], and only 4 patients
were free of disease in a follow up between 5 and
26 months [2,7,11].
As initially described by Mentzel and Katenkamp in
2000 [2] sclerosing rhabdomyosarcoma is characterized
by the production of prominent extracellular diffuse
hyaline sclerosis, with different growth patterns which
can may mimic sclerosing epitheloid fibrosarcoma,
osteosarcoma, chondrosarcoma or angiosarcoma.
Immunohistochemically sclerosing rhabdomyosarcoma
in adults shows a distinctive immunophenotype in the
expression of muscle markers, characterized by positivity
for MyoD1, negativity for Myogenin and variable
expression for Desmin and Actin muscle specific [3,7],
as occurred in the elbow tumor. Contrarily, pediatric
cases of sclerosing rhabdomyosarcoma expressed strong
immunopositivity for all muscle markers, including
MyoD1, Myogenin, Desmin and SMA, most likely
reflecting a different stage of muscle maturity [12].
The histogenic relationship between sclerosing rhab-
domyosarcoma and the other types of rhabdomyosarco-
mas remains unclear although cytogenetic studies have
suggested a link with embryonal rhabdomyosarcoma
[11,13,14].
Previous histological studies have pointed-out that
sclerosing rhabdomyosarcoma may be closely related to
embryonal rhabdomyosarcoma. Intratumoral small foci
of rhabdomyoblastic strap cells have been observed in
cases of sclerosing rhabdomyosarcoma [5,7,14]. The
most common phenomenon is the presence of a spindle
cell component, closely similar to fusocellular rhabdo-
myosarcoma, a subtype of embryonal rhabdomyosar-
coma. In fact, almost a third of the sclerosing
rhabdomyosarcomas reported in adults (5 cases) pre-
sented intratumoral microscopical foci of rhabdomyo-
blastic or spindle cell differentiation [2,3,5-7]. In
addition there are several adult cases of fusocellular
rhabdomyosarcoma containing areas of focal [10] or
extensive hyaline sclerosis [15].
In the present case we also observed spindle and rhab-
domyoblastic differentiation, but our findings have two
main differences with other cases previously reported.
First, spindle or rhabdomyoblastic differentiation
appeared only in extratumoral areas infiltrating preexist-
ing normal tissue or embolizing peritumoral vessels. No
fusocellular or rhabdomyoblastic differentiation was
identified in the sclerosing rhabdomyosarcoma. Second,
and the more important difference, the peritumoral and
intravascular infiltrating cells growing in a predominant
spindle cell pattern showed a similar histological, immu-
nohistochemical and molecular profile than that of the
Table 1 Clinicopathological findings. Chronology
CLINIPATHOLOGYCAL FINDINGS - CHRONOLOGY
DATE June 2007 July 2008 February 2009
LOCATION Mass in the right elbow Intratesticular tumor Patient died with multiple metastases in the left
thigh, lung and mediastinum.
No autopsy was performed
HISTOLOGY Eosinophilic hyalinizing sclerosing
matrix with small round cells
Fusocellular RMS with eosinophilic
matrix and rhabdomyoblasts
MITOSIS 4 mit/10HPF 10mit/10HPF
IHC (+) Vimentin Vimentin
MyoD1 MyoD1
SMA SMA
CD99 CD99
myogenin
MIB-1 25-30% 20%
RT-PCR PAX3-FKHR and PAX7-FKHR were not
found.
PAX3-FKHR and PAX7-FKHR were not
found.
FISH FOXO1A (-) FOXO1A (-)
Chemotherapy CTX+VCR+Doxorrubicin Ifosfamide
Surgery Tumor resection Right Orquidectomy
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cells from the testicular fusocellular rhabdomyosarcoma
diagnosed one year latter.
Fusocellular rhabdomyosarcoma is a type of embryo-
nal rhabdomyosarcoma that was described by Mentzel
et al. in 2006 [10]. Histologically, the tumor is made up
composed of atypical spindle-shaped tumor cells
arranged in cellular fascicles with small, oval to elon-
gated and ill-defined nuclei, small nucleoli and pale
indistinct cytoplasm. Occasionally, the tumor cells have
a varying number of rhabdomyoblasts containing abun-
dant eosinophilic cytoplasm as well as hyperchromatic
and excentrically placed enlarged nuclei. The identifica-
tion of this second cell type is a distinct indicator for
the diagnosis of fusocellular rhabdomyosarcoma [16].
Fusocellular rhabdomyosarcoma in adults arises most
frequently in the extremities as well as head and neck,
and is characterized clinically by poor prognosis, as
opposed to fusocellular rhabdomyosarcoma in children
and adolescents, which is characterized by paratesticular
location and excellent clinical prognosis [10].
Primary testicular spindle cell rhabdomyosarcoma is
extremely infrequent in adults; only isolated cases have
being described in the paratesticular region [17,18].
On the other hand, testicular metastasis from rhabdo-
myosarcoma is a very rare phenomenon, representing
approximately only 1% of testicular tumors [18,19].
Only four pediatric cases have been reported worldwide
[18-21], all corresponding to a metastasis from alveolar
rhabdomyosarcoma. In all the cases, metastatic tumors
conserved the same histological and immunohistochem-
ical phenotype of the primary tumor.
Conclusions
If our case follows this rule, it further supports that tes-
ticular spindle cell rhabdomyosarcoma represents a
metastases from the cells with spindle or rhabdomyo-
blastic differentiation infiltrating vessels or soft tissue
observed in the peritumoral vicinity of the sclerosing
rhabdomyosarcoma of the elbow. In our opinion, the
reported case highlights the close relationship between
fusocellular rhabdomyosarcoma and sclerosing rhabdo-
myosarcoma, supporting the hypothesis (at least in
adults) that most probably sclerosing rhabdomyosar-
coma represents a subtype or type of fusocellular rhab-
domyosarcoma sharing a common origin.
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